INTRODUCTION
The first cases of atypical pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were registered in December 2019, in Wuhan (China) [1]. The disease very quickly spread all over the world and, on March 11, 2020, the World Health Organization declared the...
INTRODUCTION
Modern treatment of malignant diseases has significantly improved the prognosis and survival of hemato-oncology patients [1]. In the past forty years, the ten-year survival of patients with non-Hodgkin lymphomas has increased from 20% to over 65% [2]. In addition, malignant diseases...
INTRODUCTION
Atrial fibrillation (AF) is the most frequent cardiac rhythm disturbance in clinical practice and is most commonly associated with coronary disease and hypertension. It is known, from relevant literature, that several classes of drugs (sympathomimetics, parasympathomimetics, and...
INTRODUCTION
Cardiovascular diseases (CVD) represent a large, heterogeneous group of illnesses. These diseases are the leading cause of death in most developed countries, as well as in many developing countries. The most important risk factors for CVD that can be mitigated are the following:...
INTRODUCTION
Medications are a frequent cause of thrombocytopenia, particularly among hospitalized patients. Thrombocytopenia has been associated with the use of over 300 different medications, a list of which is available at “Platelets on the web” (https://www.ouhsc.edu/ platelets/ditp.html)...
INTRODUCTION
Vitamin K antagonists (VKAs) have been a cornerstone in preventing and treating venous thromboembolism (VTE) for over half a century. However, their use also has numerous difficulties, such as a delayed onset/ offset of action, individual dosage variability, numerous drug and...
INTRODUCTION
Over the past eighteen months, the coronavirus disease 2019 (COVID-19) pandemic has caused dramatic societal, economic, and healthcare disruptions across the world. As of June 20th, 2021, in the United States alone, a total of 33,368,860 cases of COVID-19 have been reported, along...
INTRODUCTION
With the emergence of improved chemotherapeutic regimens, and the possibility of allogenic stem cell transplantation (allo-SCT), as well as with new biologic targeted therapies, the outcome for many serious hematological diseases is constantly improving [1]. However, invasive fungal...
INTRODUCTION
Thromboembolic disorders such as atrial fibrillation-related stroke, venous thromboembolism, and pulmonary embolism remain major contributors to global morbidity and mortality, making anticoagulant therapy essential in modern clinical practice [1,2,3]. While these agents are highly...
INTRODUCTION
Spinal cord injuries are a significant medical and socio-economic problem. The patients are often young individuals with a severe neurological deficit (type: quadri- or paraplegia, i.e., paresis), which is permanent in character, and which carries with it the development of...
INTRODUCTION
Depressive disorders are among the most common diseases today, with more than 350 million patients and an annual prevalence of 4.7% globally [1,2]. They are the most common mental disorders in the general population, with an incidence twice as high among women as among men....
Authors: Nađa P. Marić, Milutin Kostić, Janko Samardžić, Slobodanka Pejović- Nikolić, Olivera VukovićPublisher: Institute of Mental Health, Belgrade, 2020. ISBN 978-86-82277-69-9
Recommendations for the responsible use of benzodiazepines in mental health care in Serbia, written by Marić NP,...
INTRODUCTION
Over the past two years, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has led to the infection of millions of people all over the world, and, according to data from November 2021, it has also led to more than five...
